Valuation : Crossject

Market Cap 75.02M 87.19M 70.64M 64.37M 120M 8.3B 121M 837M 324M 4.23B 327M 320M 13.39B P/E 2026 *
3.36x
P/E 2027 * 2.65x
Enterprise Value 57.12M 66.38M 53.79M 49.01M 91.7M 6.32B 92.06M 637M 246M 3.22B 249M 244M 10.2B EV / Sales 2026 *
0.94x
EV / Sales 2027 * 0.66x
Free-Float
92.46%
Yield 2026 *
-
Yield 2027 * -
1 day-0.43%
1 week-1.43%
Current month-10.64%
1 month-8.01%
3 months-27.09%
6 months-31.10%
Current year-37.08%
1 week 1.34
Extreme 1.34
1.44
1 month 1.34
Extreme 1.34
1.72
Current year 1.34
Extreme 1.34
2.58
1 year 1.34
Extreme 1.34
2.7
3 years 0.72
Extreme 0.7199
5.96
5 years 0.72
Extreme 0.7199
5.96
10 years 0.72
Extreme 0.7199
8.19
Manager TitleAgeSince
Chief Executive Officer 63 2001-08-07
Director of Finance/CFO - 2026-03-24
Corporate Officer/Principal - 2024-08-19
Director TitleAgeSince
Chairman 67 2009-06-25
Director/Board Member 67 -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
7/4/25 Buy

Director

13,386 0.0266%
7/1/25 Buy

Director

50 0.0001%
7/1/25 Buy

Director

337 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
-0.43%-1.43%-7.76%-65.89% 87.19M
-2.23%-1.55%+148.80%+94.88% 114M
+1.52%-7.13%-23.17%-43.19% 110M
-9.32%-20.83%+71.98%+33.00% 90.03M
Average -2.62%-7.73%+47.46%+4.70% 100.32M
Weighted average by Cap. -2.40%-7.39%+50.21%+8.05%

Financials

2026 *2027 *
Net sales 60.8M 70.66M 57.25M 52.16M 97.6M 6.72B 97.99M 679M 262M 3.43B 265M 260M 10.85B 42.3M 49.16M 39.83M 36.29M 67.9M 4.68B 68.17M 472M 182M 2.38B 185M 181M 7.55B
Net income 28.3M 32.89M 26.65M 24.28M 45.43M 3.13B 45.61M 316M 122M 1.59B 123M 121M 5.05B 7.75M 9.01M 7.3M 6.65M 12.44M 857M 12.49M 86.49M 33.43M 437M 33.82M 33.08M 1.38B
Net Debt -17.9M -20.8M -16.85M -15.36M -28.73M -1.98B -28.85M -200M -77.2M -1.01B -78.11M -76.41M -3.19B -47M -54.62M -44.25M -40.32M -75.45M -5.2B -75.75M -524M -203M -2.65B -205M -201M -8.39B
Logo Crossject
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
99
Date Price Change Volume
26-09-09 €1.378 -0.43% 63,630
26-09-08 €1.384 -1.14% 133,748
26-09-07 €1.400 +4.48% 333,539
26-09-04 €1.340 -4.69% 256,963
26-09-03 €1.406 +0.57% 183,176
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.378EUR
Average target price
4.400EUR
Spread / Average Target
+219.30%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALCJ Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!